How to Preserve Muscle Mass on Weight-Loss Drugs Like Wegovy

Translate to Spanish or other 102 languages!

How can you preserve muscle mass if you are using GLP-1 drugs for weight loss? Top experts weigh in. Image for illustration purposes
How can you preserve muscle mass if you are using GLP-1 drugs for weight loss? Top experts weigh in. Image for illustration purposes
- Advertisement -

The development of glucagon-like peptide-1 (GLP-1) drugs, such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight loss, researchers and medical professionals have raised concerns about the accompanying loss of muscle tissue. This Special Feature discusses the challenges associated with assessing changes in muscle mass that accompany GLP-1 drug-induced weight loss, the potential impact of muscle mass loss, and how to preserve muscle mass.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/how-to-preserve-muscle-mass-on-weight-loss-drugs-like-wegovy

- Advertisement -

Information: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

The Truth About Liver Detoxes

Many health trends seem to come and go, but there are some that always find a way of resurfacing – like detoxing your liver.

STHS Children’s Webinar to Help Parents Protect Young Athletes from Sports-Related Injuries, Aug. 19th

Whether competing in youth sports, high school athletics or recreational leagues, young athletes continually push themselves to perform at their best. 

CDC Issues Warning Over Multistate Salmonella Outbreak Linked to Jalapeños

The Centers for Disease Control and Prevention (CDC) has issued a food safety alert following a multistate outbreak of Salmonella infections linked to contaminated jalapeño peppers

New Blood Test Spots Early Signs of Immunotherapy Effectiveness

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy.
- Advertisement -